1. Home
  2. JANX vs HLMN Comparison

JANX vs HLMN Comparison

Compare JANX & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JANX
  • HLMN
  • Stock Information
  • Founded
  • JANX 2017
  • HLMN 1964
  • Country
  • JANX United States
  • HLMN United States
  • Employees
  • JANX N/A
  • HLMN N/A
  • Industry
  • JANX Biotechnology: Pharmaceutical Preparations
  • HLMN Industrial Machinery/Components
  • Sector
  • JANX Health Care
  • HLMN Consumer Discretionary
  • Exchange
  • JANX Nasdaq
  • HLMN Nasdaq
  • Market Cap
  • JANX 1.6B
  • HLMN 2.2B
  • IPO Year
  • JANX 2021
  • HLMN N/A
  • Fundamental
  • Price
  • JANX $26.37
  • HLMN $7.68
  • Analyst Decision
  • JANX Strong Buy
  • HLMN Buy
  • Analyst Count
  • JANX 7
  • HLMN 5
  • Target Price
  • JANX $94.29
  • HLMN $11.25
  • AVG Volume (30 Days)
  • JANX 974.6K
  • HLMN 2.1M
  • Earning Date
  • JANX 05-20-2025
  • HLMN 04-29-2025
  • Dividend Yield
  • JANX N/A
  • HLMN N/A
  • EPS Growth
  • JANX N/A
  • HLMN N/A
  • EPS
  • JANX N/A
  • HLMN 0.09
  • Revenue
  • JANX $10,588,000.00
  • HLMN $1,481,633,000.00
  • Revenue This Year
  • JANX N/A
  • HLMN $5.53
  • Revenue Next Year
  • JANX $250.58
  • HLMN $4.44
  • P/E Ratio
  • JANX N/A
  • HLMN $77.97
  • Revenue Growth
  • JANX 30.99
  • HLMN 0.31
  • 52 Week Low
  • JANX $22.52
  • HLMN $6.64
  • 52 Week High
  • JANX $71.71
  • HLMN $12.08
  • Technical
  • Relative Strength Index (RSI)
  • JANX 39.10
  • HLMN 49.18
  • Support Level
  • JANX $31.34
  • HLMN $6.64
  • Resistance Level
  • JANX $33.97
  • HLMN $7.54
  • Average True Range (ATR)
  • JANX 1.94
  • HLMN 0.33
  • MACD
  • JANX -0.52
  • HLMN 0.08
  • Stochastic Oscillator
  • JANX 22.76
  • HLMN 76.75

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the group are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the US, Canada and Mexico.

Share on Social Networks: